NCOA6

Nuclear Receptor Coactivator 6

Gene Information Card

Symbol NCOA6
Full Name nuclear receptor coactivator 6
Gene Type protein-coding
Chromosomal Location 20q11.22
NCBI Gene ID 23054 ncbi.nlm.nih.gov/gene/23054
Ensembl ID ENSG00000101473
UniProt ID Q14686
OMIM ID 605299
HGNC ID 15966
Aliases ASC2, RAP250, TRBP, PRIP, NRC, AIB3, bHLHe74

Description

NCOA6 (nuclear receptor coactivator 6) encodes a transcriptional coactivator that interacts with nuclear receptors and other transcription factors to regulate gene expression. It is involved in multiple signaling pathways including steroid hormone, retinoic acid, and thyroid hormone signaling. The protein contains a basic helix-loop-helix (bHLH) domain and is essential for embryonic development, metabolism, and cell proliferation. NCOA6 is frequently amplified or overexpressed in various cancers, particularly breast and ovarian cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer Amplification and overexpression of NCOA6 enhance estrogen receptor signaling and promote tumor growth. COSMIC; ClinVar; PMID: 12037672
Ovarian cancer NCOA6 amplification contributes to oncogenic transcriptional programs. COSMIC; PMID: 15688063
Endometrial cancer NCOA6 overexpression linked to hormone-dependent tumor progression. COSMIC; PMID: 17001317
Prostate cancer NCOA6 coactivates androgen receptor, potentially driving castration-resistant growth. PMID: 15688063

Expression Profile

Tissue Expression
Tissue nTPM level
Breast 12.5 Medium
Ovary 8.3 Medium
Endometrium 10.1 Medium
Prostate 7.8 Medium
Testis 15.2 High
Brain 6.4 Low
Cell Line Expression
Cell Line nTPM Notes
MCF7 (breast cancer) 14.2 High expression; estrogen-responsive
OVCAR3 (ovarian cancer) 11.5 High expression
LNCaP (prostate cancer) 9.8 Medium expression
HEK293 (embryonic kidney) 7.3 Medium expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1234C>T (p.Arg412Trp) Missense 0.02% (COSMIC) Unknown functional effect
c.567_568insA (p.Glu190Argfs*5) Frameshift 0.01% (COSMIC) Loss of function predicted
Amplification Copy number gain 5-10% in breast cancer (COSMIC) Increased expression and coactivator activity
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations (e.g., p.Glu190Argfs*5) are predicted to cause loss of function due to premature truncation.

Gain of Function (GOF)

Gene amplification and overexpression in cancers likely represent gain-of-function events enhancing transcriptional coactivation.

Dominant Negative (DN)

No well-characterized dominant-negative mutations reported in NCOA6.

Pathways

• Nuclear receptor signaling pathway (Reactome: R-HSA-383280)
• Estrogen signaling pathway (KEGG: hsa04915)
• Thyroid hormone signaling pathway (KEGG: hsa04919)
• Retinoic acid signaling pathway

Protein Summary

NCOA6 is a 2063-amino-acid nuclear protein containing a bHLH domain and multiple LXXLL motifs that mediate interaction with nuclear receptors. It functions as a coactivator for several transcription factors including estrogen receptor, androgen receptor, retinoic acid receptor, and thyroid hormone receptor. The protein is involved in chromatin remodeling and histone acetylation through recruitment of histone acetyltransferases. NCOA6 is essential for mouse embryonic development and plays roles in metabolism, cell growth, and differentiation. Its overexpression or amplification is observed in hormone-dependent cancers.

Related Products

Product name Cat.No. Species Gene ID
NCOA6 Knockout HEK293 Cell Line EDJ-KQ7800 Human 23054 Details Get a Quote
NCOA6 Knockout A-549 Cell Line EDJ-KQ31984 Human 23054 Details Get a Quote
NCOA6 Knockout HCT 116 Cell Line EDJ-KQ33310 Human 23054 Details Get a Quote
NCOA6 Knockout HeLa Cell Line EDJ-KQ33311 Human 23054 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: